Company Information
Industry 卫生和社会工作业
Company Introduction 西安国际医学投资股份有限公司是一家国内商贸企业.主要经营国内商业、能源交通、房地产开发以及其他服务项目。 公司深耕医疗健康行业20余年,积累了丰富的医院建设、运营、管理经验,探索出适合社会办医综合性医院的高效率运营管理模式,在医疗品牌、经营体制、人才团队、医教研协同等方面形成了独具特色的核心竞争力。 公司拥有全球超大单体医院西安国际医学中心医院,全国首家社会办三甲医院西安高新医院,汇聚了中国中西部地区优质医疗人才资源以及同步国际先进水平的医疗设备,构建了提供全生命周期高水平医疗健康服务平台,品牌影响力与日俱增,目前已经打造出深耕西安,辐射中西部的综合医疗服务版图,发展成为国内大型上市医疗健康管理集团之一。 高新医院、国际医学中心医院作为妙佑医疗联盟成员医院(Mayo Clinic Care Network Member),持续与“世界最佳医院”排名第一的妙佑医疗国际密切合作,推进医疗服务与国际先进水平接轨。在实施“健康中国”战略及“十四五”深化医疗卫生改革,推动医疗卫生事业发展的历史契机下,在国家鼓励社会办医及医疗行业相关利好政策的支持下,公司必将迎来更加广阔的发展空间和前所未有的发展机遇。
Main Business 医疗服务和百货零售业。
Legal Representative 史今
Top Executives
董事长:史今
副董事长:曹鹤玲,刘旭,王爱萍
董事:孙文国,刘瑞轩
独立董事:师萍,张宝通,李富有
Top 5 Shareholder
Shareholder name Nature Holding Date
陕西世纪新元商业管理有限公司流通A股27.25%25/04/2024
申华控股集团有限公司流通A股2.68%25/04/2024
曹鹤玲限售股+流通A股1.86%25/04/2024
银河德睿资本管理有限公司流通A股1.23%25/04/2024
中国银行股份有限公司-广发医疗保健股票型证券投资基金流通A股0.81%25/04/2024
Company Secretary 丁震
Solicitors 北京市康达律师事务所
Auditors 希格玛会计师事务所(特殊普通合伙)
Tel No 029-88330516
Fax No 029-88330170
Website www.000516.cn
Email IMIC@000516.cn;IMIR@000516.cn
Company Address
Register: 陕西省西安市高新区团结南路16号保障楼5层
Office: 陕西省西安市高新区西太路777号西安国际医学中心医院保障楼
Listing Date 09/08/1993
Shares Capital
Shares Capital: 2,260,809,518
Total A Share: 2,260,809,518
Listed A Share: 2,213,559,751
Non-tradable A Share: 47,249,767
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.160
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 1.729
Market Capitalization(RMB) 13.171B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.